# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Adient has put forward restructuring plans in Europe to reduce operating, administrative and engineering costs. The plan primar...
JP Morgan analyst Ryan Brinkman maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $40 to $37.
The plans were initiated by Adient’s management as of March 31, 2024, and the affected employees were notified earlier today. A...
Barclays analyst Dan Levy downgrades Adient (NYSE:ADNT) from Overweight to Equal-Weight and lowers the price target from $41...
B of A Securities analyst John Murphy maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $50 to $46.
JP Morgan analyst Ryan Brinkman maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $41 to $40.
Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $41 to $40.